Abstract
SIGNIFICANCE
The Fitting of Orthokeratology in the United States (FOKUS) survey provides information about the United States (US) OrthoK market. This independent survey is the first to attain detailed assessment of the OrthoK market.
PURPOSE
Develop and administer a survey to eye care providers (ECP's) in the US who are managing orthokeratology patients and those who are not to determine a profile of prescribers, patients and overall market.
METHODS
The FOKUS survey was administered and distributed online. Outcome measures of the FOKUS survey involved general categories of 1) practice and practitioner profiles, 2) clinical prescribing patterns, 3) patient profile, 4) products and marketing, 5) fees and 6) market size and growth.
RESULTS
The number of ECP's who are actively fitting and managing OrthoK patients in the US is approximately 3,000. 545 responded to the survey, 283 reported they were actively fitting orthokeratology. Orthokeratology is prescribed with the intent of managing myopia by 68% of respondents, 53% monitor axial length, and 61% start OrthoK patients at age 13 years old or under. The mean number of years a patient wears OrthoK is 7.8. A commonly reported complication with orthokeratology is corneal staining. Microbial keratitis (MK) is rarely or never seen by 86% of respondents. Of those currently fitting, 56% anticipate growth of orthokeratology fitting over the next twelve months. Of those not currently fitting orthokeratology, 46% plan to start within two years.
CONCLUSIONS
Orthokeratology represents a small but growing segment of the US contact lens market. The number of practitioners actively prescribing and fitting orthokeratology in the US is approximately 3,000 with high potential for growth within the next two years. Results of the FOKUS survey are relevant to practitioners currently fitting or considering orthokeratology, manufacturers, educators and researchers as baseline for future orthokeratology market assessment.
Collapse